Business Context and Reporting Period
This Form 8-K was filed by MRI Interventions, Inc. on January 18, 2013. The filing reports the entry into a Material Definitive Agreement for a private placement financing transaction. The company is based in Memphis, Tennessee, and operates in the medical device sector.
Key Financial Metrics and Transaction Details
The filing details a financing transaction with the following specific terms:
- Gross Proceeds: Approximately $11.0 million.
- Securities Issued: Approximately 9.1 million shares of common stock and warrants to purchase approximately 4.6 million shares.
- Purchase Price: $1.20 per unit (one share plus a warrant for 0.5 share).
- Warrant Exercise Price: $1.75 per share.
- Transaction Costs: Approximately $1.1 million in commissions to placement agents (William Blair & Company, First Analysis Securities Corporation, and Brookline Group LLC).
- Expected Closing Date: On or about January 25, 2013.
The filing does not provide current revenue, profit, cash flow, or debt figures, as this is a current report regarding a specific event rather than a periodic financial statement.
Material Changes and Agreements
The primary material change is the execution of a Securities Purchase Agreement and a Registration Rights Agreement. Key provisions include:
- Registration Rights: The company must file a registration statement with the SEC within 30 calendar days of closing to cover the resale of shares and warrant-issued shares.
- Liquidated Damages: The company faces potential liquidated damages if the registration statement is not filed by the deadline, not declared effective within 75 days (or 105 days if reviewed by the SEC), or if effectiveness is not maintained.
- Warrant Features: Warrants are exercisable for five years and include a "cashless exercise" feature and adjustments for fundamental corporate transactions.
Outlook, Risks, and Contingencies
The transaction is subject to customary closing conditions. The company anticipates closing on or about January 25, 2013. A press release announcing the pricing was issued on January 22, 2013. The primary risks identified in the filing relate to the company's ability to meet the strict filing and effectiveness deadlines for the registration statement to avoid incurring liquidated damages to investors.
Investor Verification Checklist
- Verify the actual closing date of the financing transaction (anticipated January 25, 2013).
- Confirm the net proceeds after deducting the $1.1 million in placement agent commissions.
- Monitor the filing of the required registration statement within 30 days of closing to avoid liquidated damages.
- Review the full text of the Securities Purchase Agreement and Registration Rights Agreement (Exhibits 10.1 and 10.2) for specific covenants and indemnification terms.
- Check subsequent filings for the effective date of the registration statement covering the resale of the new shares.